KWM
PRTK

Kingsview Wealth Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Kingsview Wealth Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$22.1K – 1025
2023
Q2 		$22.1K Hold
10,000
– – ﹤0.01% 899
2023
Q1 		$25.4K Buy
+10,000
New +$19.8K ﹤0.01% 875

Kingsview Wealth Management's PRTK Position: Q3 2023 in Review

Kingsview Wealth Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 10,000 shares — an estimated $22.1K sold.

Kingsview Wealth Management first reported a position in PRTK in Q1 2023 and held it in 2 quarters. The position peaked at $25.4K in Q1 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Kingsview Wealth Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Kingsview Wealth Management sold 10,000 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $22.1K.
  • Kingsview Wealth Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2023 and held it in 2 quarters.
  • Kingsview Wealth Management's Paratek Pharmaceuticals, Inc. position peaked at $25.4K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Kingsview Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.